TB treatment failure
Showing 1 - 25 of >10,000
Endometrial Receptivity, Repeated Implantation Failure Trial in Shanghai (Endometrium biopsy)
Recruiting
- Endometrial Receptivity
- Repeated Implantation Failure
- Endometrium biopsy
-
Shanghai, Shanghai, ChinaShanghai Ji Ai Genetics & IVF Institute, Obstetrics and Gynecolo
Mar 31, 2021
The INSTITUT Study
Recruiting
- Tuberculosis, Pulmonary
- Undernutrition
- Nutritional support
-
Porto-Novo, Benin
- +1 more
Oct 12, 2023
Outcomes in Tuberculous Patients in Sohag Governorate
Recruiting
- Tuberculosis
- sputum analysis
- lymph node biobsy
-
Sohag, EgyptSohag university Hospital
Nov 15, 2023
Tuberculosis Infection, HIV Trial in Zomba (CAD4TB, FujiLAM)
Completed
- Tuberculosis Infection
- HIV Infections
- CAD4TB
- FujiLAM
-
Zomba, MalawiZomba Central Hospital
Jan 23, 2023
Tuberculosis, Hiv Trial (CAP, Usual Care)
Not yet recruiting
- Tuberculosis
- Hiv
- CAP
- Usual Care
- (no location specified)
Aug 10, 2022
Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)
Not yet recruiting
- Tuberculosis
- Human Immunodeficiency Virus
- Optimised rifamycin
- (no location specified)
Oct 8, 2022
Worse Outcome Post-Sars-CoV-2 Infection
Completed
- COVID-19
- +2 more
-
Johannesburg, Gauteng, South AfricaThe Aurum Institute
Jan 9, 2023
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,
Completed
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +5 more
-
Rio de Janeiro, Brazil
- +25 more
Jun 23, 2022
Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)
Recruiting
- Tuberculosis, Multidrug-Resistant
- Delamanid
- +4 more
-
Dasmariñas, Philippines
- +1 more
Jun 21, 2022
Potential Role of Microbiome in Tuberculosis
Recruiting
- Tuberculosis
-
Peshawar, KP, Pakistan
- +1 more
Jun 18, 2022
Tuberculosis, Alcohol Consumption, Treatment Adverse Effect Trial in Worcester (DOT Adherence Monitoring)
Active, not recruiting
- Tuberculosis
- +2 more
- DOT Adherence Monitoring
-
Worcester, Western Cape Province, South AfricaWorcester Community Day Centre
Jun 28, 2022
Diagnostics and Pharmacotherapy for Severe Forms of TB
Completed
- Tuberculosis
- (no location specified)
Mar 8, 2022
Contributing Factors for Poor HIV Treatment Response in TB/HIV
Recruiting
- Tuberculosis
- +2 more
- Observational study
-
Kumasi, GhanaKwame Nkrumah University of Science and Technology
Mar 23, 2022
Drug Resistant Tuberculosis Trial (Nurse-Led Treatment in Primary Care)
Not yet recruiting
- Drug Resistant Tuberculosis
- Nurse-Led Treatment in Primary Care
- (no location specified)
Dec 20, 2022
HIV/AIDS, TB - Tuberculosis, Antiretroviral Therapy, Highly Active Trial in Cape Town (PLHIV Point of Care Xpert Ultra, PLHIV
Completed
- HIV/AIDS
- +2 more
- PLHIV Point of Care Xpert Ultra
- PLHIV Point of Care Xpert VL
-
Cape Town, Western Cape, South AfricaKraaifontein Community Health Centre
Apr 4, 2022
HIV/AIDS, Tuberculosis Trial in Port-au-Prince (Same-Day Treatment, Standard treatment)
Completed
- HIV/AIDS
- Tuberculosis
- Same-Day Treatment
- Standard treatment
-
Port-au-Prince, HaitiGHESKIO
Sep 6, 2022
Tuberculosis - Learning Effect of Parasites and Reinforcing
Enrolling by invitation
- Tuberculosis, Pulmonary
- +2 more
-
Boston, Massachusetts
- +1 more
Apr 12, 2022
Tuberculosis Trial in Kota Kinabalu (Mobile Application, Direct Observed Therapy)
Not yet recruiting
- Tuberculosis
- Mobile Application
- Direct Observed Therapy
-
Kota Kinabalu, Sabah, MalaysiaMohd Fazeli bin Sazali
May 20, 2022
Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)
Not yet recruiting
- Tuberculosis, Pulmonary
- HIV
- Bedaquiline
- +6 more
-
Port-au-Prince, Haiti
- +1 more
Nov 11, 2022
Tuberculosis, Pulmonary, Rifampicin Resistant Tuberculosis Trial in Uganda (device, behavioral, other)
Active, not recruiting
- Tuberculosis, Pulmonary
- Rifampicin Resistant Tuberculosis
- GeneXpert I
- +2 more
-
Buikwe, Uganda
- +19 more
Jul 20, 2022
Pre-XDR-TB Trial in Seoul (BPaL regimen)
Not yet recruiting
- Pre-XDR-TB
- BPaL regimen
-
Seoul, Songpa-gu, Korea, Republic ofAsan Medical Center
Jul 19, 2022
SARS-CoV-2 Disease on Immune Responses, Disease Severity and
Recruiting
- COVID-19 Respiratory Infection
- Pulmonary Tuberculoses
-
Chennai, Tamilnadu, IndiaNational Institute for Research in Tuberculosis
Jul 6, 2022